Study on the New Technology of Traditional Chinese Medicine Combined with Molecular Targeted Therapy for the Treatment of Metastatic Colorectal Cancer
Ontology highlight
ABSTRACT: Interventions: The treatment group:Chemotherapy + targeted therapy + HC particles;The control group:Chemotherapy + targeted therapy + placebo particles
Primary outcome(s): Progression-Free-Survival
Study Design: Randomized parallel controlled trial
DISEASE(S): Metastatic Colorectal Cancer
PROVIDER: 2665403 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA